Orchid Pharma Limited has informed the Exchange about General Updates

We'll probably have the exact number, say, after a few months' time.

as our cefiderocol project will get started, say, in the next year, then we will take validation batches and hopefully, after two years, we would be able to -- once we are able to register the product from our side, we would be able to supply some percentage from our side.

as our cefiderocol project will get started, say, in the next year, then we will take validation batches and hopefully, after two years, we would be able to -- once we are able to register the product from our side, we would be able to supply some percentage from our side.

So, as such -- we have not considered very significant capex in the next financial year.

So we hope we can continue between 10% to 15% again this year.

we hope to have better sales on Q-o-Q basis.